Open the mobile version, with barcode scanning
Class II Terminated

LIPO-INJECTION W/METHYL B12 500 MCG/ML W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-500MCG, LIDOCAINE-10MG, METHIONINE 12.5 MG, INOSITOL 25…

Why: Lack of Assurance of Sterility

Company
Medaus, Inc.
Birmingham, AL, United States
Reported
Jul 20, 2016
Recall started
May 13, 2016
Ended
Jun 16, 2017
Where sold
U.S. Nationwide, Japan, and New Zealand.
Amount
4000 mL in Vials
Full product description
LIPO-INJECTION W/METHYL B12 500 MCG/ML W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-500MCG, LIDOCAINE-10MG, METHIONINE 12.5 MG, INOSITOL 25MG, CHOLINE CHL 25MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
Lots / codes affected
a) Lot #: 151210-40, BUD: 05/26/16; Lot #: 160229-60, BUD: 07/31/16. b) Lot #: 151210-40, BUD: 05/26/16; Lot #: 160229-60, BUD: 07/31/16.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.